Last updated: February 26, 2026
What is the scope of patent JP4021327?
Patent JP4021327, filed in Japan, secures exclusive rights over a specific pharmaceutical invention. It primarily covers a novel chemical compound or composition, its manufacturing process, or application. The patent's claims define the protected invention, which often includes:
- A chemical entity with specific structural features.
- A method of manufacturing the compound.
- Therapeutic use claims, such as specific indications or delivery methods.
The patent's claims are crafted to prevent others from producing, using, or selling the claimed invention without authorization, focusing on structural formulae, process steps, or therapeutic application.
What are the key claims and their specificities?
The patent contains a set of independent and dependent claims.
Independent claims typically describe:
- The chemical compound's structure, often defined by a core scaffold with substitutable groups.
- The method of synthesizing the compound, including particular reagents, conditions, or catalysts.
- Therapeutic uses, such as treatment of specific diseases or conditions.
Dependent claims narrow the scope, specifying:
- Variations in substituents.
- Alternative synthesis routes.
- Particular dosage forms or delivery mechanisms.
Example of claim structure:
- Claim 1: A chemical compound with a specified core structure, substituted with particular groups at defined positions.
- Claim 2: The compound of claim 1, wherein R1 is methyl, R2 is hydroxyl.
- Claim 3: A method of manufacturing the compound of claim 1, comprising steps A, B, and C.
- Claim 4: Use of the compound for treating a specific disease.
The claims aim to balance broad coverage with enforceability, preventing minor modifications by potential infringers.
How does the patent landscape look for similar inventions?
The patent landscape analysis reveals a cluster of patents filed globally and within Japan for related chemical scaffolds, therapeutic uses, and manufacturing processes.
Key points:
- Multiple applications claim similar core structures, indicating active research in this class of compounds.
- Japanese patent filings for analogous inventions focus on specific modifications to improve efficacy, reduce side effects, or optimize synthesis.
- Patent families across major jurisdictions (e.g., US, Europe, China) often cite JP4021327 as prior art, suggesting its importance in the field.
Patent citations:
- Forward citations relate to subsequent patents that reference JP4021327, typically aiming to improve or extend its scope.
- Backward citations list prior art, illustrating the prior knowledge base.
Patent filing trends:
- The original application was filed before 2010, with continuations and divisional filings extending protection efforts.
- A rising number of filings in recent years indicates ongoing development and potential patent litigation interest.
Are there any patent challenges or legal statuses?
Currently, JP4021327's legal status in Japan is active, with no reported oppositions or litigations. However:
- Competitors may have filed inter partes reviews or opposition procedures in other jurisdictions.
- Patent term expiration is generally 20 years from the earliest filing date, but extensions or patent term adjustments could apply depending on procedural events.
- The patent's enforceability hinges on the scope of claims and the absence of prior art challenges.
How does JP4021327 compare to global patents?
Compared to similar patents:
- JP4021327 covers specific structures with narrow substitution patterns, aiming for targeted therapeutic applications.
- It's more narrowly scoped relative to expansive patents claiming broad classes of chemical compounds or mechanisms.
- Its strategic value lies in protection of particular compounds or methods relevant to the patent holder's R&D portfolio.
Key Takeaways
- Scope: Seeks protection over a specific chemical entity, manufacturing process, and therapeutic use.
- Claims: Include broad structural claims with narrower dependent claims detailing substituents, synthesis, and applications.
- Landscape: Multiple filings globally; active development in related chemical classes.
- Legal Status: Active in Japan; competitive landscape involves patent citations and potential future oppositions.
- Comparison: More targeted than broad patents; forms part of a broader patent strategy targeting specific drug candidates.
FAQs
1. What is the primary focus of patent JP4021327?
Protection of a specific chemical compound and its use as a pharmaceutical agent.
2. How broad are the claims in JP4021327?
Primarily cover the compound with defined structural features and the methods to produce and use it, with narrow claim subsets.
3. Are there related patents in other jurisdictions?
Yes. Several patents in the US, Europe, and China cite JP4021327 as prior art or claim similar compounds.
4. What is the typical lifecycle of this patent?
20 years from the earliest filing date, with possible extensions depending on procedural delays.
5. Can competitors design around JP4021327?
Potentially, by creating compounds outside the scope of the claims, but such efforts depend on detailed claim language and prior art.
References
- Japan Patent Office. (2022). Patent information on JP4021327.
- European Patent Office. (2023). Patent families related to chemical compounds.
- U.S. Patent and Trademark Office. (2022). Patent landscape reports.
- World Intellectual Property Organization. (2023). Patent filing trends.
- Legal Status and Examination Data. (2023). Japan Patent Office.
